Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

  THYROID DISEASE

Antithyroid drugs and congenital malformations

A new study showed that propylthiouracil and methimazole use during pregnancy was associated with increased risk of congenital malformations. Intriguingly, the authors identified dose-dependent effects for methimazole but not propylthiouracil, whereas the recommended switch from methimazole to propylthiouracil during early pregnancy did not reduce the risk of congenital malformations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Alexander, E. K. et al. 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27, 315–389 (2017).

    Article  PubMed  Google Scholar 

  2. Milham, S. & Elledge, W. Maternal methimazole and congenital defects in children. Teratology 5, 125–125 (1972).

    Article  Google Scholar 

  3. Wolf, D., Foulds, N. & Daya, H. Antenatal carbimazole and choanal atresia: a new embryopathy. Arch. Otolaryngol. Head Neck Surg. 132, 1009–1011 (2006).

    Article  PubMed  Google Scholar 

  4. Laurberg, P. & Andersen, S. L. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur. J. Endocrinol. 171, R13–R20 (2014).

    Article  CAS  PubMed  Google Scholar 

  5. Seo, G. H., Kim, T. H. & Chung, J. H. Antithyroid drugs and congenital malformations: a nationwide Korean cohort study. Ann. Intern. Med. 168, 405–413 (2018).

    Article  PubMed  Google Scholar 

  6. Laurberg, P. & Andersen, S. L. Antithyroid drug use in pregnancy and birth defects: why some studies find clear associations, and some studies report none. Thyroid 25, 1185–1190 (2015).

    Article  CAS  PubMed  Google Scholar 

  7. Andersen, S. L., Olsen, J., Wu, C. S. & Laurberg, P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J. Clin. Endocrinol. Metab. 98, 4373–4381 (2013).

    Article  CAS  PubMed  Google Scholar 

  8. Momotani, N., Hisaoka, T., Noh, J., Ishikawa, N. & Ito, K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J. Clin. Endocrinol. Metab. 75, 738–744 (1992).

    CAS  PubMed  Google Scholar 

  9. Yoshihara, A. et al. Substituting potassium iodide for methimazole as the treatment for Graves’ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid 25, 1155–1161 (2015).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tim I. M. Korevaar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korevaar, T.I.M., Peeters, R.P. Antithyroid drugs and congenital malformations. Nat Rev Endocrinol 14, 328–329 (2018). https://doi.org/10.1038/s41574-018-0012-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-018-0012-6

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing